TY - JOUR
T1 - Extended Wear Hydrogel Lenses
T2 - Long-Term Effectiveness and Costs
AU - Cavanagh, Harrison D
AU - Bodner, B. I.
AU - Wilson, L. A.
N1 - Funding Information:
Supported in part by USPH Grant EY-01920, Research to Prevent Blindness, New York and the Georgia Lions Eye Bank, Atlanta.
PY - 1980
Y1 - 1980
N2 - During the period 1976-79, 1,201 of 1,552 aphakic patients were successfully fitted with third generation extended wear hydrogen lenses of thin-membrane design (CSI® lens) and highly hydrated polymer design (Permalens,® Sauflon®) without significant or permanent visual loss. Between 79% and 82% of the patients who failed did so in the first 90 days, and thereafter failure rates declined with time. Replacement rates for lenses approximated one lens per eye per year. Rates of required removal for cleaning varied. Ten to 13% of patients required cleaning at less than three-month intervals, and 5–6% at less than one month. For average patients with unilateral devices and no complications, extended wear lenses in Georgia are estimated to cost approximately three times as much as an intraocular lens over a 20-year follow-up period. General advantages of extended wear third generation lenses include: (1) an acceptably safe and visually effective way to correct aphakia when patients are carefully selected, fitted, educated, and followed; (2) can be easily removed, refitted or updated as technology advances; and (3) will not replace intraocular lenses, but can be used when implantation is contraindicated and should prevent the need for secondary or bilateral implantation or keratophakia in most cases.
AB - During the period 1976-79, 1,201 of 1,552 aphakic patients were successfully fitted with third generation extended wear hydrogen lenses of thin-membrane design (CSI® lens) and highly hydrated polymer design (Permalens,® Sauflon®) without significant or permanent visual loss. Between 79% and 82% of the patients who failed did so in the first 90 days, and thereafter failure rates declined with time. Replacement rates for lenses approximated one lens per eye per year. Rates of required removal for cleaning varied. Ten to 13% of patients required cleaning at less than three-month intervals, and 5–6% at less than one month. For average patients with unilateral devices and no complications, extended wear lenses in Georgia are estimated to cost approximately three times as much as an intraocular lens over a 20-year follow-up period. General advantages of extended wear third generation lenses include: (1) an acceptably safe and visually effective way to correct aphakia when patients are carefully selected, fitted, educated, and followed; (2) can be easily removed, refitted or updated as technology advances; and (3) will not replace intraocular lenses, but can be used when implantation is contraindicated and should prevent the need for secondary or bilateral implantation or keratophakia in most cases.
KW - aphakia
KW - extended wear contact lenses
UR - http://www.scopus.com/inward/record.url?scp=0019185649&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0019185649&partnerID=8YFLogxK
U2 - 10.1016/S0161-6420(80)35153-1
DO - 10.1016/S0161-6420(80)35153-1
M3 - Article
C2 - 6997789
AN - SCOPUS:0019185649
SN - 0161-6420
VL - 87
SP - 871
EP - 876
JO - Ophthalmology
JF - Ophthalmology
IS - 9
ER -